The continuous glucose monitor is a wearable sensor that measures blood glucose levels every five minutes and works in conjunction with an AI app.
read more…
The logo of Swiss pharmaceutical company Roche is seen at its factory in the central Swiss village of Rotkreuz on November 6, 2013. — Reuters
Swiss pharmaceutical giant Roche said on Tuesday it will soon begin selling a device that uses artificial intelligence to predict the likelihood of nighttime hypoglycemia, helping diabetics get a better night's sleep.
Diabetes is a chronic metabolic disease characterised by elevated blood sugar levels and is treated with insulin injections. Patients can suffer from hypoglycemia, a drop in blood sugar levels at night that can disrupt sleep and may require medical intervention.
Roche said its latest continuous glucose monitor is a wearable sensor that measures blood glucose levels every five minutes and works with an AI app.
“An integrated AI-powered predictive algorithm indicates your risk of hypoglycemia within the next 30 minutes, continuously predicts how your blood glucose levels will change over the next two hours, and estimates your risk of hypoglycemia overnight,” the company said.
The technology allows for “proactive intervention before blood glucose levels require immediate attention” and is “designed to reduce the concern and lower the risk of nocturnal hypoglycemia,” Roche added.
The company said it determined that its predictive AI algorithms exceeded high performance requirements in terms of accuracy and that the system met European health and safety standards.
While generative AI applications like ChatGPT have garnered the most attention, artificial intelligence is increasingly being deployed in a variety of areas, including language translation and image recognition, including assisting medical professionals.
According to the World Health Organization (WHO), more than 422 million people worldwide had diabetes in 2014, and rising obesity is contributing to an increase in the number of people with type 2 diabetes, which develops when the body becomes resistant to insulin or does not produce enough insulin.
